NuLeaf Naturals is Well Positioned to Serve as Supplier to Participating Organizations Under the CMS Innovation Center's Beneficiary Engagement Incentive CALGARY, AB, April 1, 2026 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, today announced that its wholly owned U.S. hemp-derived CBD subsidiary, NuLeaf Naturals, intends to purs

- Bambusa's lead product candidate, BBT001 is a next-generation long-acting bispecific antibody targeting two clinically and commercially validated targets, IL-4Rα and IL-31 for the treatment of atopic dermatitis (AD) and other type 2 inflammatory skin diseases - - BBT001 achieved rapid, deep, and sustained effects on key biomarkers of interest in AD for at least 12 weeks, including reduction of TARC and inhibition of pSTAT6 - - BBT001 was well tolerated across all doses in both the single- an

AGOURA HILLS, Calif.--(BUSINESS WIRE)--A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage immunotherapy company developing first-in-class logic-gated therapies for solid tumors, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for A2B543, an autologous CAR T-cell therapy designed for the treatment of germline heterozygous HLA-A*02 adults with recurrent unresectable, locally advanced, or metastatic solid tumors that express MSLN and have lost HL

Contrave, the #1 branded oral non-GLP-1 weight loss medication* is now available to self-funded employers through Peek BRENTWOOD, Tenn., April 1, 2026 /PRNewswire/ -- Currax Pharmaceuticals LLC ("Currax"), a specialty pharmaceutical company and manufacturer of the #1 branded oral non-GLP-1 weight loss medication CONTRAVE® (naltrexone HCl/bupropion HCl)*, today announced expanded access to CONTRAVE® through PeekDirect, in partnership with Peek Healthcare Technologies, Inc. ("Peek"). PeekDirect i

The Oberkotter Foundation is requesting proposals for projects that promote the use of hearing devices during all waking hours in children who are deaf or hard of hearing. PHILADELPHIA, April 1, 2026 /PRNewswire/ -- Today, the Oberkotter Foundation announced a new funding opportunity seeking proposals for projects that promote the use of hearing devices during all waking hours in infants and young children. With this request for proposals, the Foundation's goal is to invest in solutions to assis

HONG KONG, April 1, 2026 /PRNewswire/ -- The release of Innogen's inaugural annual report following its Hong Kong listing serves not merely as a financial disclosure, but as a strategic milestone—offering investors and stakeholders critical insights into the company's transition from R&D-driven innovation to sustainable commercial execution. The most significant indicator in the report is the robust commercial performance of its lead asset, Efsubaglutide α, during its first full year on the mar

Industry veteran with more than 20 years of experience to lead the company's next phase of expansion in the specialty generics pharmaceuticals market. ALLEGAN, Mich., April 1, 2026 /PRNewswire/ -- Padagis® today announced the appointment of Pamela Hoffman as Chief Executive Officer. Since Padagis' establishment in 2021, Ms. Hoffman has taken on roles of increasing responsibility, including serving as its Chief Financial Officer and, most recently, its President. Ms. Hoffman will continue to lea

CENTREVILLE, Va.--(BUSINESS WIRE)--Goodlabs, a health technology company that partners with nonprofit blood centers, today announced a pilot launch with Inova that offers optional free, clinical-grade bloodwork to eligible donors who book and complete a blood donation through the Goodlabs platform. Blood donations among younger Americans are down 40%. Goodlabs pairs free, clinical-grade wellness panels with blood donation to reverse the trend. The partnership is designed to support two goals at

Augments Jukebox Health's home safety and independence ecosystem to help Managed Care Organizations modernize legacy care management systems and lower total cost of care for high-need, dual-eligible populations. NEW YORK, April 1, 2026 /PRNewswire/ -- Jukebox Health, a leader in advancing safety and independence at home, today announced the acquisition of Braided Health, a care management technology company serving high-need, dual-eligible Medicare-Medicaid populations. With this acquisition, Ju

The Team Behind Continual-G Dives Into the Results of a New Study on Liposomal Glutathione — and Why It's Not Telling Us What We Need to Know. FORT LAUDERDALE, Fla., April 1, 2026 /PRNewswire/ -- A new study has reported the effectiveness of raising glutathione levels in the blood through oral supplementation of liposomal glutathione. However, the team at Inid Research Labs that developed the breakthrough cellular glutathione supplement Continual-G sees a weak spot, not in the research but in th